000 01862 a2200565 4500
005 20250515201624.0
264 0 _c20100310
008 201003s 0 0 eng d
022 _a1546-1696
024 7 _a10.1038/nbt.1595
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZhou, Yinghui
245 0 0 _aChimeric mouse tumor models reveal differences in pathway activation between ERBB family- and KRAS-dependent lung adenocarcinomas.
_h[electronic resource]
260 _bNature biotechnology
_cJan 2010
300 _a71-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdenocarcinoma
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aChimera
_xmetabolism
650 0 4 _aDisease Models, Animal
650 0 4 _aEmbryonic Stem Cells
_xdrug effects
650 0 4 _aErbB Receptors
_xmetabolism
650 0 4 _aLung Neoplasms
_xmetabolism
650 0 4 _aMice
650 0 4 _aMice, Transgenic
650 0 4 _aMutation
_xgenetics
650 0 4 _aPhenotype
650 0 4 _aPiperazines
_xpharmacology
650 0 4 _aProto-Oncogene Proteins p21(ras)
_xmetabolism
650 0 4 _aQuinazolines
_xpharmacology
650 0 4 _aRespiratory Insufficiency
_xmetabolism
650 0 4 _aSignal Transduction
_xdrug effects
700 1 _aRideout, William M
700 1 _aZi, Tong
700 1 _aBressel, Angela
700 1 _aReddypalli, Shailaja
700 1 _aRancourt, Rebecca
700 1 _aWoo, Jin-Kyeung
700 1 _aHorner, James W
700 1 _aChin, Lynda
700 1 _aChiu, M Isabel
700 1 _aBosenberg, Marcus
700 1 _aJacks, Tyler
700 1 _aClark, Steven C
700 1 _aDepinho, Ronald A
700 1 _aRobinson, Murray O
700 1 _aHeyer, Joerg
773 0 _tNature biotechnology
_gvol. 28
_gno. 1
_gp. 71-8
856 4 0 _uhttps://doi.org/10.1038/nbt.1595
_zAvailable from publisher's website
999 _c19404527
_d19404527